RxDoctor Payments Data

Yael Kushner, PA

Physician Assistant · Ft Lauderdale, FLNPI 1730433483

Payments from drug & device makers

$4,892in general payments, 2019–2025

Across 161 payments — averaging $30.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$1K
  • GSK$536
  • CSL Behring$518
  • AstraZeneca$371
  • Optinose US, Inc.$346
  • Takeda Pharmaceuticals U.S.A., Inc.$312
  • plus $2K from 22 others

What the payments were for

  • Food & beverage$4,878100%
  • Education$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,892 in reported general payments places this provider in the 90th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$29,838
Medicare patients
88
Services billed
1,375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab12$46,384
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$14,067
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,394
DuleraMometasone/Formoterol11$3,901
Arnuity ElliptaFluticasone Furoate11$3,779
Azelastine Hcl43$796
Ipratropium Bromide20$759
Albuterol Sulfate HfaAlbuterol Sulfate22$545
Fluticasone Propionate29$412
Montelukast Sodium19$114
Levocetirizine Dihydrochloride13$113

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere$371$14,06721 claims
GSKTrelegy Ellipta, Arnuity Ellipta$536$12,17324 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Ft Lauderdale

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →